Phase Forward and SGS Life Science Services - Clinical Research Sign Multi-Year, Multi-Million Dollar Agreement
Published: Aug 13, 2009
WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year, multi-million dollar extension of its existing partnership with leading CRO SGS. The agreement reinforces the companies’ close working relationship and offers SGS’s customers the benefits of Phase Forward’s InForm™ Global Trial Management (GTM), Clarix™ Interactive Response Technology (IRT) and Maaguzi Web-based electronic patient reported outcomes (ePRO) and late phase solutions. A Phase Forward customer since 2002, SGS is one of the largest EU data management CROs, managing nearly 100 clinical trials and processing over one million case report form (CRF) pages each year.